Paul Kemp is a molecular biologist from Imperial College, London, who researches the genomics of muscle wasting in critical illness. Some surprising numbers here: how fast is our normal muscle turnover? What is the rate of critical illness myopathy, and does it matter?
Can we predict who gets myopathy, and if we can, what do we do about it? Are there future applications where we can predict how patients will react? And if mitochondira react in the muscles, are they also reacting in other tissues? Should we be stopping the process or not?
A great mix of basic science and clinical outcomes.
Podcast: Play in new window | Download